# FDA Inspection 1118826 - Biocon Limited - January 24, 2020

Source: https://www.keypedia.com/records/fda_inspections/biocon-limited/b985e7a5-5d70-454c-9a38-cd8ce642507c
Source feed: FDA_Inspections

> FDA Inspection 1118826 for Biocon Limited on January 24, 2020. Classification: Voluntary Action Indicated (VAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1118826
- Company Name: Biocon Limited
- Inspection Date: 2020-01-24
- Classification: Voluntary Action Indicated (VAI)
- Project Area: Drug Quality Assurance
- Product Type: Drugs
- Office Name: Center for Drug Evaluation and Research

## Related Documents

- [FDA Inspection 1251543 - 2024-09-27](https://www.keypedia.com/records/fda_inspections/biocon-limited/20922827-e36e-4825-9006-952542f44cb0)
- [FDA Inspection 985205 - 2016-07-08](https://www.keypedia.com/records/fda_inspections/biocon-limited/11b96dd2-ed5b-4a8b-acea-05c0bb4f4aed)

Company: https://www.keypedia.com/companies/biocon-limited/7b8920c7-f5be-4f17-8100-3bede3943790

Office: https://www.keypedia.com/offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c